How do you pay?

How to pay the least

Ask for the cash price

Doptelet

We didn’t find one.

  1. Ask your pharmacy for Doptelet’s cash price, and one or two other pharmacies too.
  2. Doptelet’s savings card works only with insurance from a job or one you bought.

Compare every option

Question
Brand nameDoptelet
Authorized genericavatrombopag
Regular genericavatrombopag
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldNone found
Same as Doptelet?
The original
–
–

Brand nameThe maker’s card

Doptelet Copay Assistance Program

Savings card from Sobi, Inc. (AkaRx)

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a prescription

The card takes up to $15,000 a year off your co-pay.

Sign up on sobipatientsupport.iassist.com 

Or call 1-833-368-2663. See the offer on doptelet.com

In the maker’s words

“Eligible patients may pay as little as $0 for each Doptelet prescription…”

From the maker’s offer on doptelet.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Doptelet itself, from the same company, sold without the brand name, and usually for less. For now Doptelet is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

We didn’t find one. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

DOPTELET is a thrombopoietin receptor agonist indicated for the treatment of:

  • Thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo a procedure.
  • Thrombocytopenia in adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment.
  • Thrombocytopenia in pediatric patients 1 year and older with persistent or chronic immune thrombocytopenia who have had an insufficient response to a previous treatment

Source: the FDA label for Doptelet (AkaRx, Inc.), August 13, 2025. Full label on DailyMed 

Good to know